bevacizumab 中文意思是什麼
bevacizumab
解釋
貝伐單抗-
For example, the use of bevacizumab for colorectal cancer and erlotinib for lung cancer in the united states was 10 times higher than the european average
例如，美國應用貝伐單抗治療直腸結腸癌以及埃羅替尼治療肺癌是歐洲平均水平的10倍。 -
The largest disparities were in the use of the new colorectal and lung cancer drugs : bevacizumab, cetuximab, erlotinib and pemetrexed, the study found
差別最為懸殊的是新型抗結腸直腸癌及肺癌藥物的應用，這些藥物包括貝伐單抗、西妥昔單抗、埃羅替尼及培美曲塞。 -
Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclinical and clinical activity against metastatic colorectal cancer, particularly in combination with chemotherapy
背景：一種新型的抗血管內皮單克隆抗體貝伐單抗在基礎以及臨床研究中均對轉移性結腸癌表現出良好的治療效果，尤其在與其他化療藥物結合時效果更佳。 -
Conclusions the addition of bevacizumab to paclitaxel plus carboplatin in the treatment of selected patients with non ? small - cell lung cancer has a significant survival benefit with the risk of increased treatment - related deaths. ( clinicaltrials. gov number, nct00021060 [ clinicaltrials. gov ]
結論：紫杉醇-卡鉑加上貝伐單抗治療非小細胞肺癌，可明顯延長生存期，但治療相關性死亡風險也同時升高。 -
Yes, the authors did compile their report with an unrestricted grant by roche pharmaceuticals, which is clearly acknowledged, and some ? but by no means all ? of the drugs they assess in detail, such as trastuzumab for breast cancer and bevacizumab for colon cancer, are made or marketed by roche
確實，作者明確承認撰寫此報告羅氏制藥公司給予他們大力幫助，提供了部分藥物使用情況（絕不是他們詳細評估的所有藥物） ，如羅氏製造或經銷的曲妥單抗（治療乳腺癌）和貝伐單抗（治療結腸癌） 。
分享友人